- Home
- APLT vs NCTY Comparison
APLT vs NCTY Comparison
Compare APLT & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- NCTY
- Stock Information
- Founded
- APLT 2016
- NCTY 1999
- Country
- APLT United States
- NCTY China
- Employees
- APLT N/A
- NCTY N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- NCTY Business Services
- Sector
- APLT Health Care
- NCTY Consumer Discretionary
- Exchange
- APLT Nasdaq
- NCTY Nasdaq
- Market Cap
- APLT 128.0M
- NCTY 135.7M
- IPO Year
- APLT 2019
- NCTY 2004
- Fundamental
- Price
- APLT $0.65
- NCTY $16.77
- Analyst Decision
- APLT Buy
- NCTY
- Analyst Count
- APLT 7
- NCTY 0
- Target Price
- APLT $6.10
- NCTY N/A
- AVG Volume (30 Days)
- APLT 7.5M
- NCTY 142.8K
- Earning Date
- APLT 03-05-2025
- NCTY 01-01-0001
- Dividend Yield
- APLT N/A
- NCTY N/A
- EPS Growth
- APLT N/A
- NCTY N/A
- EPS
- APLT N/A
- NCTY 9.91
- Revenue
- APLT N/A
- NCTY $24,286,983.00
- Revenue This Year
- APLT N/A
- NCTY N/A
- Revenue Next Year
- APLT $2,622.90
- NCTY N/A
- P/E Ratio
- APLT N/A
- NCTY $3.72
- Revenue Growth
- APLT N/A
- NCTY 2.82
- 52 Week Low
- APLT $0.60
- NCTY $4.04
- 52 Week High
- APLT $10.62
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- APLT 20.60
- NCTY 59.29
- Support Level
- APLT $0.60
- NCTY $13.68
- Resistance Level
- APLT $0.74
- NCTY $16.56
- Average True Range (ATR)
- APLT 0.09
- NCTY 1.24
- MACD
- APLT 0.21
- NCTY -0.05
- Stochastic Oscillator
- APLT 13.53
- NCTY 81.10
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China and other areas.